One - , 3 - , and 5-year recurrence-free survival rates were 78.1 % , 56.5 % , and 36.9 % in the adjuvant RT group and 72.4 % , 40.1 % , and 16.0 % in the control group , respectively ( p = 0.06 , log-rank test ) .